News you can use: health & drug safety updates


  • September 2, 2015
    Some consumers seeking to change their skin color are turning to injectable products marketed to whiten or lighten their complexion. These products are potentially unsafe and ineffective, and might contain unknown harmful ingredients or contaminants. FDA has not approved any injectable drugs for skin whitening or lightening. Beyond the potential harm from the product itself, improper or unsafe injection practices may transmit disease, cause infection and result in serious injury. What Consumers Should Do
  • September 1, 2015

    APhA Pharmacy Today

  • August 25, 2015
    FDA is warning consumers about children’s cough-and-cold medicine with codeine, the risks of nonsteroidal anti- inflammatory drugs (NSAIDs), unapproved prescription ear products and drugs from Moses Lake Professional Pharmacy.
  • August 21, 2015
    The website, launched by Purdue Pharma, LP, aims to educate healthcare providers and patients about abuse- deterrent opioid-based painkillers. Purdue markets two of the three opioid formulations available with the abuse- deterrent properties. The site features sections about why it’s critical to deter abuse and how all the members on the healthcare team can make a difference. It also outlines the 2015 Food & Drug Administration’s Guidance on Abuse-Deterrent Opioids — Evaluation and Labeling, which informs drug developers about FDA’s current thinking on
  • August 20, 2015
    Pharmacists in one study made a significant impact in helping heart patients stick to their medication regimens, report researchers. A multidisciplinary team at the US Department of Veterans Affairs talked to patients from a previous study who adhered to their medications after suffering an acute coronary syndrome, or an episode when blood is blocked from the heart, reports Pharmacy Times. These patients cited “supportive and concerned” pharmacists who called to remind them to take their medicine as a key factor in actually doing so. The study
  • August 18, 2015
    In a Guidance to industry document issued August 4, the FDA endorsed the use of flow restrictors for over-the- counter (OTC) pediatric oral liquid drug products containing acetaminophen. “OTC pediatric oral liquid drug products containing acetaminophen have been associated with overdoses due to medication errors that resulted in serious adverse events, including severe liver damage and death, the FDA notes in the Guidance. This guidance is designed to help “drug manufacturers, packagers, and labelers minimize the risk to consumers of acetaminophen-related liver
  • August 13, 2015

    NCPIE’s Talk Before You Take campaign launched earlier this year. A recent article published in the Washington Post, “The Risky Business of Taking Antibiotics,” highlighted the story of a patient named Barbara Odanaka, who experienced fluoroquinolone toxicity after being prescribed an antibiotic called levofloxacin while she was hospitalized with severe pneumonia. Odanaka noted in the article that levofloxacin’s potential adverse effects were not properly explained to her. Pharmacy Today/

  • August 13, 2015
    Adverse drug events (ADEs) are the largest contributor to hospital-related complications and account for more than 3.5 million physician office visits each year. The U.S. Department of Health and Human Services (HHS) recently released the National Action Plan for Adverse Drug Event Prevention (ADE Action Plan), which targets opioids as a significant contributor to ADEs. The new, interactive training, “Pathways to Safer Opioid Use,” teaches health care providers how to implement
  • August 11, 2015
    As parents and caregivers fill out a multitude of forms at the start of the school year, they may have questions about some requirements, including the vaccine schedule. According to Marion Gruber, Ph.D., director of the Office of Vaccines Research and Review at the Food and Drug Administration (FDA), vaccines are integral to get children off to a healthy start. “Parents should know that vaccines protect children from many serious illnesses from infectious diseases. The risk of being harmed by vaccines is much smaller than the risk of serious illness from infectious diseases,” she says.
  • August 10, 2015
    Article by Dan Leonard, President of the National Pharmaceutical Council and Member NCPIE Board of Directors